Fibroblast growth factor-2 is a sputum remodeling biomarker of severe asthma

References

• Holgate ST. Pathogenesis of asthma. Clin Exp Allergy 2008;38:872–897
   PubMed Web of Science ®Google Scholar
• Masoli M, Fabian D, Holt S, Beasley R. Global burden of asthma. Developped for the Global Initiative for Asthma: Medical Research Institute of New-Zealand, Wellintgon, New Zealand and University of Southampton, Southampton, United Kingdom; 2004. Available at: http://www.ginasthma.com/ReportItem.asp?l1=2&l2=2&intId=94 [last accessed Jun 2013]
   Google Scholar
• Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012;18:716–725
   PubMed Web of Science ®Google Scholar
• Wadsworth S, Sin D, Dorscheid D. Clinical update on the use of biomarkers of airway inflammation in the management of asthma. J Asthma Allergy 2011;4:77–86
   PubMedGoogle Scholar
• Szefler SJ, Wenzel S, Brown R, Erzurum SC, Fahy JV, Hamilton RG, Hunt JF, et al. Asthma outcomes: biomarkers. J Allergy Clin Immunol 2012;129:S9–S23
   PubMed Web of Science ®Google Scholar
• Diamant Z, Boot JD, Mantzouranis E, Flohr R, Sterk PJ, Gerth van Wijk R. Biomarkers in asthma and allergic rhinitis. Pulm Pharmacol Ther 2010;23:468–481
   PubMed Web of Science ®Google Scholar
• Al-Muhsen S, Johnson JR, Hamid Q. Remodeling in asthma. J Allergy Clin Immunol 2011;128:451–62 ; quiz 63–64
   PubMed Web of Science ®Google Scholar
• Bosse Y, Rola-Pleszczynski M. FGF2 in asthmatic airway-smooth-muscle-cell hyperplasia. Trends Mol Med 2008;14:3–11
   PubMed Web of Science ®Google Scholar
• Royce SG, Cheng V, Samuel CS, Tang ML. The regulation of fibrosis in airway remodeling in asthma. Mol Cell Endocrinol 2012;351:167–175
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2012. Available at: http://www.ginasthma.org/ [last accessed Jun 2013]
   Google Scholar
• Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, Squillace D, Gleich GJ, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996;154:308–317
   PubMed Web of Science ®Google Scholar
• Hackett TL. Epithelial-mesenchymal transition in the pathophysiology of airway remodelling in asthma. Curr Opin Allergy Clin Immunol 2012;12:53–59
   PubMed Web of Science ®Google Scholar
• Chakir J, Hamid Q, Bosse M, Boulet LP, Laviolette M. Bronchial inflammation in corticosteroid-sensitive and corticosteroid-resistant asthma at baseline and on oral corticosteroid treatment. Clin Exp Allergy 2002;32:578–582
   PubMed Web of Science ®Google Scholar
• Series F, Chakir J, Boivin D. Influence of weight and sleep apnea status on immunologic and structural features of the uvula. Am J Respir Crit Care Med 2004;170:1114–1119
   PubMedGoogle Scholar
• Swanney MP, Ruppel G, Enright PL, Pedersen OF, Crapo RO, Miller MR, Jensen RL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008;63:1046–1051
   PubMed Web of Science ®Google Scholar
• Short PM, Lipworth SI, Lipworth BJ. Relationships between airway hyperresponsiveness, inflammation, and calibre in asthma. Lung 2011;189:493–497
   Google Scholar
• James AL, Bai TR, Mauad T, Abramson MJ, Dolhnikoff M, McKay KO, Maxwell PS, et al. Airway smooth muscle thickness in asthma is related to severity but not duration of asthma. Eur Respir J 2009;34:1040–1045
   PubMed Web of Science ®Google Scholar
• Kanazawa H, Yoshikawa T. Up-regulation of thrombin activity induced by vascular endothelial growth factor in asthmatic airways. Chest 2007;132:1169–1174
   PubMedGoogle Scholar
• Redington AE, Roche WR, Madden J, Frew AJ, Djukanovic R, Holgate ST, Howarth PH. Basic fibroblast growth factor in asthma: measurement in bronchoalveolar lavage fluid basally and following allergen challenge. J Allergy Clin Immunol 2001;107:384–387
   PubMed Web of Science ®Google Scholar
• Shute JK, Solic N, Shimizu J, McConnell W, Redington AE, Howarth PH. Epithelial expression and release of FGF-2 from heparan sulphate binding sites in bronchial tissue in asthma. Thorax 2004;59:557–562
   Google Scholar
• Yum HY, Cho JY, Miller M, Broide DH. Allergen-induced coexpression of bFGF and TGF-beta1 by macrophages in a mouse model of airway remodeling: bFGF induces macrophage TGF-beta1 expression in vitro. Int Arch Allergy Immunol 2011;155:12–22
   Google Scholar
• Yang YC, Zhang N, Van Crombruggen K, Hu GH, Hong SL, Bachert C. Transforming growth factor-beta1 in inflammatory airway disease: a key for understanding inflammation and remodeling. Allergy 2012;67:1193–1202
   PubMed Web of Science ®Google Scholar
• Burgess WH, Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 1989;58:575–606
   PubMed Web of Science ®Google Scholar
• Bentley JK, Hershenson MB. Airway smooth muscle growth in asthma: proliferation, hypertrophy, and migration. Proc Am Thorac Soc 2008;5:89–96
   PubMedGoogle Scholar
• Hassan M, Jo T, Risse PA, Tolloczko B, Lemiere C, Olivenstein R, Hamid Q, Martin JG. Airway smooth muscle remodeling is a dynamic process in severe long-standing asthma. J Allergy Clin Immunol 2010;125:1037–1045e3
   PubMed Web of Science ®Google Scholar
• Kaminska M, Foley S, Maghni K, Storness-Bliss C, Coxson H, Ghezzo H, Lemière C, et al. Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction. J Allergy Clin Immunol 2009;124:45–51 e1–e4
   PubMed Web of Science ®Google Scholar
• Gueders MM, Foidart JM, Noel A, Cataldo DD. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. Eur J Pharmacol 2006;533:133–144
   PubMed Web of Science ®Google Scholar
• Cataldo DD, Gueders M, Munaut C, Rocks N, Bartsch P, Foidart JM, Noël A, Louis R. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases mRNA transcripts in the bronchial secretions of asthmatics. Lab Invest 2004;84:418–424
   PubMed Web of Science ®Google Scholar
• Huang CD, Lin SM, Chang PJ, Liu WT, Wang CH, Liu CY, Lin HC, et al. Matrix metalloproteinase-1 polymorphism is associated with persistent airway obstruction in asthma in the Taiwanese population. J Asthma 2009;46:41–46
   PubMed Web of Science ®Google Scholar
• Wenzel SE, Balzar S, Cundall M, Chu HW. Subepithelial basement membrane immunoreactivity for matrix metalloproteinase 9: association with asthma severity, neutrophilic inflammation, and wound repair. J Allergy Clin Immunol 2003;111:1345–1352
   PubMed Web of Science ®Google Scholar
• Culpitt SV, Rogers DF, Traves SL, Barnes PJ, Donnelly LE. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma. Respir Med 2005;99:703–710
   PubMed Web of Science ®Google Scholar
• Obase Y, Rytila P, Metso T, Pelkonen AS, Tervahartiala T, Turpeinen M, Mäkelä M, et al. Effects of inhaled corticosteroids on metalloproteinase-8 and tissue inhibitor of metalloproteinase-1 in the airways of asthmatic children. Int Arch Allergy Immunol 2010;151:247–254
   Google Scholar
• Chaudhuri R, McSharry C, Brady J, Donnelly I, Grierson C, McGuinness S, Jolly L, et al. Sputum matrix metalloproteinase-12 in patients with chronic obstructive pulmonary disease and asthma: relationship to disease severity. J Allergy Clin Immunol 2012;129:655–663 e8
   PubMed Web of Science ®Google Scholar
• Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE, Dolovich J. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992;47:25–29
   PubMed Web of Science ®Google Scholar
• Woolhouse IS, Bayley DL, Stockley RA. Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis. Thorax 2002;57:667–671
   PubMed Web of Science ®Google Scholar